Publication | Closed Access

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

UrologyMetastatic Urothelial CarcinomaPhase Ii TrialGenitourinary CancerMedicineCancer TreatmentOncologyRadiation OncologyMolecular Oncology